Atlas Trials

Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

Clinical trial NCT02510118 · UNKNOWN

Trial details

NCT number
NCT02510118
Sponsor
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Colon Cancer
Start date
2015-06-01
Primary completion
2016-06-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.